RAC1 and atrial fibrillation: This is in full accordance with the observation that statins, which reduce ROS production by NADPH oxidases via inhibition of Rac1, are effective in acute models of AF and in patients with post-operative AF, but fail to reduce ROS production in models of long-lasting AF or patients with permanent AF.